Implications of Normal Brain Development for the Pathogenesis of Schizophrenia

Archives of General Psychiatry

Volumn 44, Issue 7, 1987, Pages 660-669

  Weinberger, Daniel R ^a  

^a NATIONAL INSTITUTE OF MENTAL HEALTH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BRAIN DEVELOPMENT; CENTRAL NERVOUS SYSTEM; CLINICAL ARTICLE; DIENCEPHALON; ETIOLOGY; HUMAN; LIMBIC SYSTEM; MATURATION; PATHOGENESIS; PRIORITY JOURNAL; SCHIZOPHRENIA; STRESS;

ADOLESCENT; ADULT; AGE FACTORS; ANIMAL; BRAIN; BRAIN DISEASES; BRAIN STEM; CHILD; CHILD, PRESCHOOL; DOPAMINE; FRONTAL LOBE; HUMAN; LIMBIC SYSTEM; MODELS, NEUROLOGICAL; RATS; RECEPTORS, DOPAMINE; SCHIZOPHRENIA; SCHIZOPHRENIC PSYCHOLOGY; STRESS, PSYCHOLOGICAL;

EID: 0023215296     PISSN: 0003990X     EISSN: 15383636     Source Type: Journal    
DOI: 10.1001/archpsyc.1987.01800190080012     Document Type: Article

References (106)

1. Meltzer HY, Stahl SM: The dopamine hypothesis of schizophrenia: A review. Schizophr Bull 1976;2:19-76.
2. Weinberger DR, Kleinman JE: Observations on the brain in schizophrenia, in Hales RE, Frances AJ (eds): Psychiatry Update, American Psychiatric Association Annual Review. Washington, DC, American Psychiatric Association Press, 1986, vol 5, pp 42-67.
3. Weinberger DR: The pathogenesis of schizophrenia: A neurodevelopmental theory, in Nasrallah HA, Weinberger DR (eds): The Neurology of Schizophrenia. Amsterdam, Elsevier Science Publishers, 1986, pp 397-406.
4. Adams RD, Lyons G: Neurology of Hereditary Metabolic Diseases of Children. New York, McGraw-Hill International Book Co, 1982, pp 5-6, 376-381.
5. Bogerts B, Meertz E, Schonfeldt-Bausch R: Basal ganglia and limbic system pathology in schizophrenia: A morphometric study. Arch Gen Psychiatry 1985;42:784-791.
6. Jakob H, Beckmann H: Prenatal development disturbances in the limbic allocortex in schizophrenics. J Neural Transm 1986;65:303-326.
7. Stevens JR: Neuropathology of schizophrenia. Arch Gen Psychiatry 1982;39:1131-1139.
8. Brown R, Colter N, Corsellis JAN, Crow TJ, Frith CD, Jagoe R, Johnstone EC, Marsh L: Postmortem evidence of structural brain changes in schizophrenia. Arch Gen Psychiatry 1986;43:36-42.
9. Kovelman JA, Scheibel AB: A neurohistological correlate of schizophrenia. Biol Psychiatry 1984;19:1601-1621.
10. Lesch A, Bogerts B: The diencephalon in schizophrenia: Evidence for reduced thickness of the periventricular grey matter. Eur Arch Psychiatry Neurol Sci 1984;234:212-219.
11. Nieto D, Escobar A: Major psychoses, in Minkler J (ed): Pathology of the Nervous System. New York, McGraw-Hill International Book Co, 1972, pp 2654-2665.
12. Averback P: Lesions of the nucleus ansa peduncularis in neuropsychiatric disease. Arch Neurol 1981;38:230-235.
13. Bogerts B, Hantsch J, Herzer M: A morphometric study of the dopamine containing cell groups in the mesencephalon of normals, Parkinson patients and schizophrenics. Biol Psychiatry 1983;18:951-969.
14. Falkai P, Bogerts B: Cell loss in the hippocampus of schizophrenics. Eur Arch Psychiatry Neurol Sci, in press.
15. Benes FM, Davidson J, Bird ED: Quantitative cytoarchitectural studies of the cerebral cortex of schizophrenics. Arch Gen Psychiatry 1986;43:31-35.
16. Kirch DG, Weinberger DR: Anatomical neuropathology in schizophrenia: Post-mortem findings, in Nasrallah HA, Weinberger DR (eds): The Neurology of Schizophrenia. Amsterdam, Elsevier Science Publishers, 1986, pp 325-348.
17. Shelton RC, Weinberger DR: X-Ray computerized tomography studies of schizophrenia: A review and synthesis, in Nasrallah HA, Weinberger DR (eds): The Neurology of Schizophrenia. Amsterdam, Elsevier Science Publishers, 1986, pp 207-250.
18. Fuster J: The Prefrontal Cortex. New York, Raven Press, 1980.
19. Isaacson RL. The Limbic System. New York, Plenum Publishing Corp, 1982.
20. Gloor P, Olivier A, Quesney LF, Anderman F, Horowitz S: The role of the limbic system in experiential phenomena of temporal lobe epilepsy. Ann Neurol 1982;12:129-144.
21. Halgren E, Walter RD, Cherlow DG, Crandall PH: Mental phenomena evoked by electrical stimulation of the human hippocampal formation and amygdala. Brain 1978;101:83-117.
22. Davison K, Bagley CR: Schizophrenia-like psychoses associated with organic disorders of the central nervous system. Br J Psychiatry 1969;113 (suppl 1):18-69.
23. Davison K: Schizophrenia-like psychoses associated with organic cerebral disorders: A review. Psychiatr Dev 1983;1:1-34.
24. Strauss JS, Carpenter WT Jr, Bartko JJ: The diagnosis and understanding of schizophrenia: III. Speculations on the processes that underlie schizophrenic symptoms and signs. Schizophr Bull 1974;1:61-69.
25. Andreasen NC: Negative vs positive schizophrenia. Arch Gen Psychiatry 1982;39:784-788.
26. Seidman LJ: Schizophrenia and brain dysfunction: An integration of recent neurodiagnostic findings. Psychol Bull 1984;94:195-235.
27. Goldberg TE, Weinberger DR: Methodological issues in the neuropsychological approach to schizophrenia, in Nasrallah HA, Weinberger DR (eds): The Neurology of Schizophrenia. Amsterdam, Elsevier Science Publishers, 1986, pp 141-156.
28. Stuss DT, Benson DF: Neuropsychological studies of the frontal lobes. Psychol Bull 1984;95:3-28.
29. Dimascio A: The frontal lobes, in Heilman KM, Valenstein E (eds): Clinical Neuropsychology. New York, Oxford University Press, 1979, pp 360-412.
30. Grafman J, Vance SC, Weingartner H, Salazar AM: Specific effects of orbito-frontal brain wounds upon regulation of mood. Neuropsychologia, in press.
31. Hecaen H, Albert ML: Disorders of mental functioning related to the frontal lobes, in Benson DF, Blumer D (eds): Psychiatric Aspects of Neurological Disease. New York, Grune & Stratton, 1975, 137-149.
32. Weinberger DR, Berman KF, Zec RF: Physiological dysfunction of dorsolateral prefrontal cortex in schizophrenia: I. Regional cerebral blood flow (rCBF) evidence. Arch Gen Psychiatry 1986;43:114-125.
33. Berman KF, Zec RF, Weinberger DR: Physiological dysfunction of dorsolateral prefrontal cortex in schizophrenia: II. Role of medication, attention, and mental effort. Arch Gen Psychiatry 1986;43:126-143.
34. Weinberger DR, DeLisi LE, Perman G, Targum S, Wyatt RJ: Computed tomography scans in schizophreniform disorder and other acute psychiatric patients. Arch Gen Psychiatry 1982;39:778-783.
35. Nyback H, Berggren BM, Hindmarsh T: Computed tomography of the brain in patients with acute psychosis and in healthy volunteers. Acta Psychiatr Scand 1982;65:403-414.
36. Schultz SC, Koller MM, Kishore P: Ventricular enlargement in teenage patients with schizophrenia spectrum disorder. Am J Psychiatry 1983;140:1592-1595.
37. Weinberger DR, Cannon-Spoor E, Potkin SG, Wyatt RJ: Poor premorbid adjustment and CT scan abnormalities in chronic schizophrenia. Am J Psychiatry 1980;137:1410-1413.
38. DeLisi LE, Schwartz CC, Targum SD, Byrnes SM, Cannon-Spoor E, Weinberger DR, Wyatt RJ: Ventricular brain enlargement and outcome of acute schizophrenic disorder. J Psychiatr Res 1983;9:169-171.
39. Williams AO, Reveley MA, Kolakowska T, Andern M, Mandelbrote BM: Schizophrenia with good and poor outcome: II. Cerebral ventricular size and its clinical significance. Br J Psychiatry 1985;146:239-246.
40. Turner SW, Toone BK, Brett-Jones JR: Computerized tomographic scan changes in early schizophrenia. Psychol Med 1986;16:219-225.
41. Glaser GH: Limbic epilepsy in childhood. J Nerv Ment Dis 1967;144:391-397.
42. Chandler JH, Reed TE, DeJong RN: Huntington's chorea in Michigan: III. Clinical observations. Neurology 1960;10:148-153.
43. Garron DC: Huntington's chorea and schizophrenia, in Barbeau A, Chase TN, Paulson 0 (eds): Advances in Neurology. New York, Raven Press, 1973, pp 729-734.
44. Beard AW: The association of hepatolenticular degeneration with schizophrenia. Acta Neurol Scand 1959;34:411-428.
45. Manowitz P, Kling A, Kohn H: Clinical course of adult metachromatic leukodystrophy presenting as schizophrenia. J Nerv Ment Dis 1978;166:500-506.
46. Cummings JL, Gosenfeld LF, Houlihan JP, McCaffrey T: Neuropsychiatric disturbances associated with idiopathic calcification of the basal ganglia. Biol Psychiatry 1983;18:591-601.
47. Greenbaum JV, Lurie LA: Encephalitis as a causative factor in behavioral disorders of children. JAMA 1948;136:923-930.
48. Feinglass EJ, Arnett FC, Dorsch CA, Zizic M, Stevens MD: Neuropsychiatric manifestations of systemic lupus erythematosus: Diagnosis, clinical spectrum and relationship to other features of the disease. Medicine 1976;55:323-339.
49. Brown P, Rodgers-Johnson P, Cathala F, Gibbs CJ, Gadjusek DG: Creutzfeldt-Jakob disease of long duration: Clinicopathological characteristics, transmissibility, and differential diagnosis. Ann Neurol 1984;16:295-304.
50. Achte KA, Hillbom E, Salberg V: Psychoses following war brain injuries. Acta Psychiatr Scand 1969;45:1-18.
51. Ludwig CL, Smith MT, Godfrey AD, Armbrustmacher V: A clinicopathological study of 323 patients with oligodendrogliomas. Ann Neurol 1986;19:15-21.
52. Hruska RE, Silbergeld EK: Increased dopamine receptor sensitivity after estrogen treatment using the rat rotation model. Science 1980;208:1466-1468.
53. Goldman-Rakic PS, Isseroff A, Schwartz ML, Bugbee NM: The neurobiology of cognitive development, in Mussen P (ed): Handbook of Child Psychology, Biology and Infancy Development. New York, John Wiley & Sons Inc, 1983, pp 281-344.
54. Yakovlev PI, LeCours A-R: The myelogenetic cycles of regional maturation of the brain, in Minkowski A (ed): Regional Development of the Brain in Early Life. Boston, Blackwell Scientific Publications Inc, 1964, pp 3-70.
55. Huttenlocher PR: Synaptic density in human frontal cortex: Developmental changes and effects of aging. Brain Res 1979;163:195-205.
56. Rakic P, Bourgeois J-P, Eckenhoff MF, Zecevic N, Goldman-Rakic PS: Concurrent overproduction of synapses in diverse regions of the primate cerebral cortex. Science 1986;232:232-235.
57. Ingvar DH: ‘Memory of the future’: An essay on the temporal organization of conscious awareness. Hum Neurobiol 1985;4:127-136.
58. Piaget J: The Origins of Intelligence in Children. New York, WW Norton & Co Inc, 1963.
59. Milner B: Effects of different brain lesions on card sorting. Arch Neurol 1963;9:100-110.
60. Kirk V, Kelly MS: Children's differential performance in selected dorsolateral prefrontal and posterior cortical functions: A developmental perspective. Presented at the International Neuropsychological Society Annual Meeting, Denver, Jan 17, 1986.
61. Goldman PS, Alexander GE: Maturation of prefrontal cortex in the monkey revealed by local reversible cryogenic depression. Nature 1977;267:613-615.
62. Tucker TJ, Kling A: Differential effects of early and late lesions of frontal granular cortex in the monkey. Brain Res 1967;5:377-389.
63. Goldman PS: Functional development of the prefrontal cortex in early life and the problem of neuronal plasticity. Exp Neurol 1971;32:366-387.
64. Kraepelin E: Dementia Praecox and Paraphenia. Melbourne, Fla, Robert E Krieger Publishing Co Inc, 1971.
65. Bleuler E: Dementia Praecox or the Group of Schizophrenias. New York, New York International Press, 1950.
66. Fish B: Neurobiologic antecedents of schizophrenia in children. Arch Gen Psychiatry 1977;34:1297-1313.
67. Goldberg T, Weinberger DR: Methodological issues in the neuropsychological approach to schizophrenia, in Nasrallah HA, Weinberger DR (eds): The Neurology of Schizophrenia. Amsterdam, Elsevier Science Publishers, 1986, pp 141-156.
68. Carlsson A: Antipsychotic drugs, neurotransmitters and schizophrenia. Am J Psychiatry 1978;135:164-173.
69. Creese I, Burt DR, Snyder SH: Dopamine receptor binding predicts clinical and pharmacological potencies of antischizophrenic drugs. Science 1976;192:481-483.
70. Crow TJ: Positive and negative schizophrenic symptoms and the role of dopamine. Br J Psychiatry 1980;137:383-386.
71. Seeman P, Ulpian C, Bergeron C: Bimodal distribution of dopamine receptor densities in brains of schizophrenics. Science 1984;225:728-731.
72. Wong DF, Wagner HN Jr, Tune LE, Dannals RF, Pearlson GD, Links JM, Tamminga CA, Broussolle EP, Ravert HT, Wilson AA, Thomas Toung JK, Malat J, Williams JA, O'Tuama LA, Snyder SH, Kuhar MJ, Gjedde A: Positron emission tomography reveals elevated D2 dopamine receptors in drug-naive schizophrenics. Science 1986;234:1558-1563.
73. Glowinski J, Tassin JP, Thierry AM: The mesocorticoprefrontal dopaminergic neurons. Trends Neurosci 1984;7:415-418.
74. Brozowski TJ, Brown RM, Rosvold HE, Goldman PS: Cognitive deficit caused by regional depletion of dopamine in prefrontal cortex of rhesus monkey. Science 1979;205:929-932.
75. Langston JW, Ballard P, Tetrud JW, Irwin I: Chronic parkinsonism in humans due to a product of meperidine-analogue synthesis. Science 1983;219:979-980.
76. Stern Y, Langston JW: Intellectual changes in patients with MPTPinduced parkinsonism. Neurology 1985;35:1506-1509.
77. Bowen FP, Kamienny RS, Burns MM, Yahr ND: Parkinsonism: Effects of levodopa treatment on concept formation. Neurology 1975;25:701-704.
78. Scatton B, Rouquier L, Javoy-Agid F, Agid Y: Dopamine deficiency in the cerebral cortex in Parkinson disease. Neurology 1982;32:1039-1040.
79. Gerlack J, Luhdorf K: The effect of L-dopa on young patients with simple schizophrenia treated with neuroleptic drugs: A double-blind crossover trial with madopar and placebo. Psychopharmacology 1975;44:105-110.
80. Ogura C, Kishimoto A, Nakao T: Clinical effects of L-dopa on schizophrenia. Curr Ther Res 1976;20:308-318.
81. Rifkin A, Quitkin F, Klein DF: Akinesia. Arch Gen Psychiatry 1975;32:672-674.
82. Elsworth JD, Leahy DJ, Roth RH Jr, Redmond D Jr: Homovanillic acid concentrations in brain, CSF and plasma as indicators of central dopamine function in primates. J Neural Transm 1987;68:51-62.
83. Lindstrom LH: Low HVA and normal 5HIAA CSF levels in drug-free schizophrenic patients compared to healthy volunteers: Correlations to symptomatology and family history. Psychiatry Res 1985;14:265-273.
84. Weinberger DR, Berman KF: Huntington's disease and subcortical dementia: rCBF evidence. Neurology 1985;35(suppl 1):109.
85. Weinberger DR, Berman KF, Chase TN: Prefrontal cortex physiological activation in Parkinson's disease: Effect of L-dopa. Neurology 1986;36 (suppl 1):170.
86. McCulloch J, Savaki HE, McCulloch MC: The distribution of alterations in energy metabolism in the rat brain produced by apomorphine. Brain Res 1982;243:67-80.
87. Pycock CJ, Kerwin RW, Carter CJ: Effect of lesion of cortical dopamine terminals on subcortical dopamine in rats. Nature 1980;286:74-77.
88. Thierry A-M, Tassin J-P, Glowinski J: Biochemical and electrophysical studies of the mesocortical dopamine system, in Descarsies L, Reader TR, Jasper HH (eds): Monoamine Innervation of Cerebral Cortex. New York, Alan R Liss Inc, 1984, pp 233-262.
89. Bliss EL, Ailion J: Relationship of stress and activity to brain dopamine and homovanillic acid. Life Sci 1971;10:1161-1169.
90. Thierry AM, Tassin JP, Blanc G, Glowinski J: Selective activation of the mesocortical DA system by stress. Nature 1976;263:242-244.
91. Herman JP, Guilloneau D, Dantzer R: Differential effects of inescapable foot shocks and of stimuli previously paired with inescapable foot shock on dopamine turnover in cortical and limbic areas of the rat. Life Sci 1982;30:2207-2214.
92. Tam S-Y, Roth RH: Selective increase in dopamine metabolism in the prefrontal cortex by the anxiogenic beta-carboline FG 7142. Biochem Pharmacol 1985;34:1595-1598.
93. Goldman-Rakic PS, Brown RM: Postnatal development of monoamine content and synthesis in the cerebral cortex of rhesus monkeys. Dev Brain Res 1982;4:339-349.
94. McGeer PL, McGeer EG: Neurotransmitters in the aging brain, in Darrison AM, Thompson RH (eds): The Molecular Basis of Neuropathology. London, Edward Arnold Ltd, 1981, pp 631-648.
95. Bzowej NH, Seeman P: Age and dopamine D2 receptors in human brain. Soc Neurosci Abstr 1985;11:889.
96. Wong DF, Wagner HN Jr, Dannals RF, Links JM, Frost JJ, Ravert HT, Wilson AA, Rosenbaum AE: Effects of age on dopamine and serotonin receptors measured by positron emission tomography in the living human brain. Science 1984;226:1393-1396.
97. Pfohl B, Winokur G: The evolution of symptoms in institutionalized hebephrenic catatonic schizophrenics. Br J Psychiatry 1982;141:567-572.
98. Kandel ER: From metapsychology to molecular biology: Explorations into the nature of anxiety. Am J Psychiatry 1983;140:1277-1293.
99. Haracz JL: Neural plasticity in schizophrenia. Schizophr Bull 1985;11:191-229.
100. Zubin J, Spring B: Vulnerability: A new view of schizophrenia. J Abnorm Psychol 1977;86:103-126.
101. Kendler KS: Genetics of schizophrenia, in Hales RE, Frances AJ (eds): Psychiatry Update, American Psychiatric Association Annual Review. Washington, DC, American Psychiatric Association Press, 1986, pp 42-67.
102. Meltzer HY: Biology of schizophrenia subtypes: A review and proposal for method of study. Schizophr Bull 1979;5:460-479.
103. Crow TJ: Molecular pathology of schizophrenia: More than one disease process. Br Med J 1980;280:66-68.
104. Bannon MJ, Roth RH: Pharmacology of mesocortical dopamine neurons. Pharmacol Rev 1983;35:53-68.
105. Liberman RP, Musser KT, Wallace CT: Social skill training for schizophrenic individuals at risk for relapse. Am J Psychiatry 1986;147:523-526.
106. Linn MQW, Caffey EM, Klett J, Hogarty GE, Lamb HR: Day treatment and psychotropic drugs in the aftercare of schizophrenic patients. Arch Gen Psychiatry 1979;36:1055-1066.